Literature DB >> 26246259

Lateral Tibiocalcaneal Angle As a Determinant for Percutaneous Achilles Tenotomy for Idiopathic Clubfeet.

Seungcheol Kang1, Soo-Sung Park1.   

Abstract

BACKGROUND: The aim of the present study was to evaluate the clinical value of using the lateral tibiocalcaneal (LTiC) angle, measured on a lateral radiograph made with the foot and ankle in maximal dorsiflexion, instead of the ankle dorsiflexion (ADF) angle, measured on physical examination, as a determining indicator of the need for percutaneous Achilles tenotomy after Ponseti serial cast treatment of idiopathic clubfoot.
METHODS: We identified patients with idiopathic clubfoot who had been treated at our institution between March 2006 and June 2012. After exclusion of patients with Diméglio grade-I clubfoot and those followed for less than two years, 125 idiopathic clubfeet were evaluated. The clubfeet were grouped according to their LTiC and ADF angles, after which we evaluated the clinical outcomes of each group and investigated the prognostic effects of each angle-based decision regarding whether to perform percutaneous Achilles tenotomy.
RESULTS: Patients with a favorable LTiC angle (≤80°) showed no sagittal relapse even though none underwent percutaneous Achilles tenotomy. In contrast, patients with an unfavorable LTiC angle (>80°) had a high chance of sagittal relapse if percutaneous Achilles tenotomy had not been performed, even when they had a favorable ADF angle (≥15°). The LTiC-angle-based decision showed the most significant prognostic value in multivariate analyses of relapse-free and surgery-free survival rates.
CONCLUSIONS: The LTiC angle measured on simple radiographs is a more objective and prognostic indicator of the need for percutaneous Achilles tenotomy, as compared with the ADF angle measured on physical examination, in patients with idiopathic clubfoot. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 26246259     DOI: 10.2106/JBJS.O.00076

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  6 in total

1.  Comparison of Dimeglio and Pirani score in predicting number of casts and need for tenotomy in clubfoot correction using the Ponseti method.

Authors:  Manuele Lampasi; Caterina Novella Abati; Camilla Bettuzzi; Stefano Stilli; Giovanni Trisolino
Journal:  Int Orthop       Date:  2018-03-29       Impact factor: 3.075

2.  The Predictive Value of Radiographs and the Pirani Score for Later Additional Surgery in Ponseti-Treated Idiopathic Clubfeet, an Observational Cohort Study.

Authors:  Sophie Moerman; Nienke Zijlstra-Koenrades; Max Reijman; Dagmar R J Kempink; Johannes H J M Bessems; Suzanne de Vos-Jakobs
Journal:  Children (Basel)       Date:  2022-06-10

3.  Are early antero-posterior and lateral radiographs predictive of clubfoot relapse requiring surgical intervention in children treated by Ponseti method?

Authors:  Jingchun Li; Chenchen Xu; Yiqiang Li; Yuanzhong Liu; Hongwen Xu; Federico Canavese
Journal:  J Child Orthop       Date:  2022-04-05       Impact factor: 1.917

Review 4.  Relapses in clubfoot treated with Ponseti technique and standard bracing protocol- a systematic analysis.

Authors:  Anil Agarwal; Anuj Rastogi; Prateek Rastogi
Journal:  J Clin Orthop Trauma       Date:  2021-05-02

5.  Interobserver reliability of Diméglio and Pirani score and their subcomponents in the evaluation of idiopathic clubfoot in a clinical setting: a need for improved scoring systems.

Authors:  C Bettuzzi; C N Abati; G Salvatori; A Zanardi; M Lampasi
Journal:  J Child Orthop       Date:  2019-10-01       Impact factor: 1.548

6.  Prognostic factors for recurrent idiopathic clubfoot deformity: a systematic literature review and meta-analysis.

Authors:  Heleen Van Schelven; Sophie Moerman; Marieke Van der Steen; Arnold T Besselaar; Christian Greve
Journal:  Acta Orthop       Date:  2022-01-03       Impact factor: 3.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.